Applied Therapeutics, Inc. General and Administrative Expense
Applied Therapeutics, Inc. reported General and Administrative Expense of $8.16 million for the 3-month period ending 2025-09-30, per its 10-Q filed 2025-11-13.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:GeneralAndAdministrativeExpense · last filed 2025-11-13
- Applied Therapeutics, Inc. general and administrative expense for the quarter ending 2025-09-30 was $8.16M, a 45.75% decline year-over-year.
- Applied Therapeutics, Inc. general and administrative expense for the quarter ending 2025-06-30 was $13.18M, a 24.53% increase year-over-year.
- Applied Therapeutics, Inc. general and administrative expense for the quarter ending 2025-03-31 was $17.69M, a 95.10% increase year-over-year.
- Applied Therapeutics, Inc. general and administrative expense for the quarter ending 2024-12-31 was $21.33M, a 323.32% increase year-over-year.
- Applied Therapeutics, Inc. general and administrative expense for fiscal 2024 was $56.01M, a 171.59% increase from fiscal 2023.
- Applied Therapeutics, Inc. general and administrative expense for fiscal 2023 was $20.62M, a 24.50% decline from fiscal 2022.
- Applied Therapeutics, Inc. general and administrative expense for fiscal 2022 was $27.32M, a 36.55% decline from fiscal 2021.
- Applied Therapeutics, Inc. general and administrative expense for fiscal 2021 was $43.05M, a 31.73% increase from fiscal 2020.
| Period end | General and Administrative Expense 3 month | General and Administrative Expense 6 month | General and Administrative Expense 9 month | General and Administrative Expense 12 month |
|---|---|---|---|---|
| 2025-09-30 | $8.16M 10-Q · filed 2025-11-13 | $21.33M derived: sum of 2 quarters · filed 2025-11-13 | $39.02M 10-Q · filed 2025-11-13 | $60.35M derived: sum of 4 quarters · filed 2025-11-13 |
| 2025-06-30 | $13.18M 10-Q · filed 2025-08-13 | $30.86M 10-Q · filed 2025-08-13 | $52.19M derived: sum of 3 quarters · filed 2025-08-13 | $67.23M derived: sum of 4 quarters · filed 2025-11-13 |
| 2025-03-31 | $17.69M 10-Q · filed 2025-05-14 | $39.02M derived: sum of 2 quarters · filed 2025-05-14 | $54.05M derived: sum of 3 quarters · filed 2025-11-13 | $64.63M derived: sum of 4 quarters · filed 2025-11-13 |
| 2024-12-31 | $21.33M derived: 10-K 12 month − 10-Q 9 month · filed 2025-04-15 | $36.36M derived: sum of 2 quarters · filed 2025-11-13 | $46.94M derived: sum of 3 quarters · filed 2025-11-13 | $56.01M 10-K · filed 2025-04-15 |
| 2024-09-30 | $15.04M 10-Q · filed 2025-11-13 | $25.62M derived: sum of 2 quarters · filed 2025-11-13 | $34.68M 10-Q · filed 2025-11-13 | $39.72M derived: sum of 4 quarters · filed 2025-11-13 |
| 2024-06-30 | $10.58M 10-Q · filed 2025-08-13 | $19.65M 10-Q · filed 2025-08-13 | $24.68M derived: sum of 3 quarters · filed 2025-08-13 | $29.39M derived: sum of 4 quarters · filed 2025-08-13 |
| 2024-03-31 | $9.07M 10-Q · filed 2024-05-09 | $14.10M derived: sum of 2 quarters · filed 2025-04-15 | $18.81M derived: sum of 3 quarters · filed 2025-04-15 | $24.11M derived: sum of 4 quarters · filed 2025-04-15 |
| 2023-12-31 | $5.04M derived: 10-K 12 month − 10-Q 9 month · filed 2025-04-15 | $9.75M derived: sum of 2 quarters · filed 2025-04-15 | $15.04M derived: sum of 3 quarters · filed 2025-04-15 | $20.62M 10-K · filed 2025-04-15 |
| 2023-09-30 | $4.71M 10-Q · filed 2024-11-07 | $10.00M derived: sum of 2 quarters · filed 2024-11-07 | $15.59M 10-Q · filed 2024-11-07 | $22.47M derived: sum of 4 quarters · filed 2024-11-07 |
| 2023-06-30 | $5.29M 10-Q · filed 2024-08-07 | $10.88M 10-Q · filed 2024-08-07 | $17.76M derived: sum of 3 quarters · filed 2024-08-07 | $24.00M derived: sum of 4 quarters · filed 2024-08-07 |
| 2023-03-31 | $5.58M 10-Q · filed 2024-05-09 | $12.46M derived: sum of 2 quarters · filed 2024-05-09 | $18.70M derived: sum of 3 quarters · filed 2024-05-09 | $24.83M derived: sum of 4 quarters · filed 2024-05-09 |
| 2022-12-31 | $6.88M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-06 | $13.12M derived: sum of 2 quarters · filed 2024-03-06 | $19.25M derived: sum of 3 quarters · filed 2024-03-06 | $27.32M 10-K · filed 2024-03-06 |
| 2022-09-30 | $6.24M 10-Q · filed 2023-11-09 | $12.37M derived: sum of 2 quarters · filed 2023-11-09 | $20.44M 10-Q · filed 2023-11-09 | $31.83M derived: sum of 4 quarters · filed 2023-11-09 |
| 2022-06-30 | $6.13M 10-Q · filed 2023-08-10 | $14.20M 10-Q · filed 2023-08-10 | $25.59M derived: sum of 3 quarters · filed 2023-08-10 | $36.42M derived: sum of 4 quarters · filed 2023-08-10 |
| 2022-03-31 | $8.07M 10-Q · filed 2023-05-11 | $19.46M derived: sum of 2 quarters · filed 2023-05-11 | $30.29M derived: sum of 3 quarters · filed 2023-05-11 | $41.37M derived: sum of 4 quarters · filed 2023-05-11 |
| 2021-12-31 | $11.39M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-23 | $22.22M derived: sum of 2 quarters · filed 2023-03-23 | $33.30M derived: sum of 3 quarters · filed 2023-03-23 | $43.05M 10-K · filed 2023-03-23 |
| 2021-09-30 | $10.83M 10-Q · filed 2022-11-09 | $21.91M derived: sum of 2 quarters · filed 2022-11-09 | $31.66M 10-Q · filed 2022-11-09 | $41.59M derived: sum of 4 quarters · filed 2022-11-09 |
| 2021-06-30 | $11.07M 10-Q · filed 2022-08-12 | $20.82M 10-Q · filed 2022-08-12 | $30.76M derived: sum of 3 quarters · filed 2022-08-12 | $40.78M derived: sum of 4 quarters · filed 2022-08-12 |
| 2021-03-31 | $9.75M 10-Q · filed 2022-05-12 | $19.68M derived: sum of 2 quarters · filed 2022-05-12 | $29.70M derived: sum of 3 quarters · filed 2022-05-12 | $37.23M derived: sum of 4 quarters · filed 2022-05-12 |
| 2020-12-31 | $9.93M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-10 | $19.95M derived: sum of 2 quarters · filed 2022-03-10 | $27.48M derived: sum of 3 quarters · filed 2022-03-10 | $32.68M 10-K · filed 2022-03-10 |
| 2020-09-30 | $10.02M 10-Q · filed 2021-11-12 | $17.54M derived: sum of 2 quarters · filed 2021-11-12 | $22.74M 10-Q · filed 2021-11-12 | $26.64M derived: sum of 4 quarters · filed 2021-11-12 |
| 2020-06-30 | $7.52M 10-Q · filed 2021-08-12 | $12.72M 10-Q · filed 2021-08-12 | $16.62M derived: sum of 3 quarters · filed 2021-08-12 | $19.91M derived: sum of 4 quarters · filed 2021-08-12 |
| 2020-03-31 | $5.20M 10-Q · filed 2021-05-11 | $9.10M derived: sum of 2 quarters · filed 2021-05-11 | $12.39M derived: sum of 3 quarters · filed 2021-05-11 | $16.57M derived: sum of 4 quarters · filed 2021-05-11 |
| 2019-12-31 | $3.90M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-18 | $7.20M derived: sum of 2 quarters · filed 2021-03-18 | $11.38M derived: sum of 3 quarters · filed 2021-03-18 | $13.23M 10-K · filed 2021-03-18 |
| 2019-09-30 | $3.29M 10-Q · filed 2020-11-12 | $7.48M derived: sum of 2 quarters · filed 2020-11-12 | $9.33M 10-Q · filed 2020-11-12 | $9.96M derived: sum of 4 quarters · filed 2020-11-12 |
| 2019-06-30 | $4.18M 10-Q · filed 2020-08-11 | $6.04M 10-Q · filed 2020-08-11 | $6.67M derived: sum of 3 quarters · filed 2020-08-11 | $7.26M derived: sum of 4 quarters · filed 2020-08-11 |
| 2019-03-31 | $1.85M 10-Q · filed 2020-05-11 | $2.48M derived: sum of 2 quarters · filed 2020-05-11 | $3.08M derived: sum of 3 quarters · filed 2020-05-11 | $3.48M derived: sum of 4 quarters · filed 2020-05-11 |
| 2018-12-31 | $629.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-13 | $1.23M derived: sum of 2 quarters · filed 2020-03-13 | $1.63M derived: sum of 3 quarters · filed 2020-03-13 | $2.05M 10-K · filed 2020-03-13 |
| 2018-09-30 | $598.00K 10-Q · filed 2019-11-13 | $998.00K derived: sum of 2 quarters · filed 2019-11-13 | $1.42M 10-Q · filed 2019-11-13 | |
| 2018-06-30 | $400.00K 10-Q · filed 2019-08-12 | $820.00K 10-Q · filed 2019-08-12 | ||
| 2018-03-31 | $420.00K 10-Q · filed 2019-06-21 |